MedTrace Logo

Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging)

NCT03535077 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 186

Last updated 2024-01-10

No results posted yet for this study

Summary

The goal of the SFI is to provide non-invasive information about tissue remodeling occurring during melanocytic transition and atypia development in the skin

Conditions

  • Skin Lesion
  • Melanoma (Skin)
  • Mole

Interventions

OTHER

Diagnostic Test

Imaging of the suspicious lesion after application of ORL-1 dye prior to biopsy

Sponsors & Collaborators

  • Orlucent, Inc

    lead INDUSTRY

Principal Investigators

  • Cathy Shachaf, PhD · President

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-24
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03535077 on ClinicalTrials.gov